Abstract |
KB-5424 (ab-(3-aminopyrrolidine)-cd-[glycolato (2-)-0, 0'] platinum (II) is a newly developed antitumor platinum compound which was synthesized at Kanebo Institute for Cancer Research. When the antitumor activity of KB-5424 was evaluated using several rodent tumors, no significant differences were observed between the antitumor activities of KB-5424, cisplatin (CDDP) and DWA-2114 R (DWA). KB-5424 was divided into two kinds of optical isomers, KB-5424 R and KB-5424 S, of which antitumor activity was compared each other. The maximum increased life span (ILSmax) on L 1210 of KB-5424 R was almost equal to that of CDDP and better than those of KB-5424 S and carboplatin ( CBDCA). The antitumor activity of KB-5424 R on a human tumor xenograft MX-1 was almost identical to those of CDDP and CBDCA and better than that of DWA. Since the nephrotoxicity of KB-5424 R was significantly reduced comparing with CDDP, this newly developed antitumor platinum compound was thought to be a promising agent for the clinical application.
|
Authors | H Yamaguchi, T Kubota, T Takahara, T Takeuchi, T Furukawa, S Kase, K Josui, S Kodaira, K Ishibiki, O Abe |
Journal | Gan to kagaku ryoho. Cancer & chemotherapy
(Gan To Kagaku Ryoho)
Vol. 18
Issue 7
Pg. 1135-41
(Jun 1991)
ISSN: 0385-0684 [Print] Japan |
PMID | 2053772
(Publication Type: Comparative Study, English Abstract, Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Organoplatinum Compounds
- DWA 2114
- KB 5424
- Carboplatin
- Cisplatin
|
Topics |
- Animals
- Antineoplastic Agents
(adverse effects, chemistry, therapeutic use)
- Carboplatin
(analogs & derivatives, therapeutic use)
- Cisplatin
(therapeutic use)
- Drug Screening Assays, Antitumor
- Kidney
(drug effects)
- Male
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Neoplasm Transplantation
- Neoplasms, Experimental
(drug therapy)
- Optical Rotation
- Organoplatinum Compounds
(administration & dosage, therapeutic use)
- Rats
- Rats, Inbred F344
|